6 research outputs found
Recommended from our members
Testis-specific serine kinase protein family in male fertility and as targets for non-hormonal male contraception
Male contraception is a very active area of research. Several hormonal agents have entered clinical trials, while potential non-hormonal targets have been brought to light more recently and are at earlier stages of development. The general strategy is to target genes along the molecular pathways of sperm production, maturation, or function, and it is predicted that these novel approaches will hopefully lead to more selective male contraceptive compounds with a decreased side effect burden. Protein kinases are known to play a major role in signaling events associated with sperm differentiation and function. In this review, we focus our analysis on the testis-specific serine kinase (TSSK) protein family. We have previously shown that members of the family of TSSKs are postmeiotically expressed in male germ cells and in mature mammalian sperm. The restricted postmeiotic expression of TSSKs as well as the importance of phosphorylation in signaling processes strongly suggests that TSSKs have an important role in germ cell differentiation and/or sperm function. This prediction has been supported by the reported sterile phenotype of the Tssk6 knockout (KO) mice and of the double Tssk1 and Tssk2 KO mice and by the male subfertile phenotype observed in a Tssk4 KO mouse model
TSSK3, a novel target for male contraception, is required for spermiogenesis
We have previously shown that members of the family of testis-specific serine/threonine kinases (TSSKs) are post-meiotically expressed in testicular germ cells and in mature sperm in mammals. The restricted post-meiotic expression of TSSKs as well as the importance of phosphorylation in signaling processes strongly suggest that TSSKs have an important role in germ cell differentiation and/or sperm function. This prediction has been supported by the reported sterile phenotype of the TSSK6 knock-out (KO) mice and of the double TSSK1/TSSK2 KO. The aim of this study was to develop KO mouse models of TSSK3 and to validate this kinase as a target for the development of a male contraceptive. We used CRISPR/Cas9 technology to generate the TSSK3 KO allele on B6D2F1 background mice. Male heterozygous pups were used to establish three independent TSSK3 KO lines. After natural mating of TSSK3 KO males, females that presented a plug (indicative of mating) were monitored for the following 24 days and no pregnancies or pups were found. Sperm numbers were drastically reduced in all three KO lines and, remarkably, round spermatids were detected in the cauda epididymis of KO mice. From the small population of sperm recovered, severe morphology defects were detected. Our results indicate an essential role of TSSK3 in spermiogenesis and support this kinase as a suitable candidate for the development of novel nonhormonal male contraceptives.Fil: Nayyab, Saman. University of Massachussets; Estados UnidosFil: Gervasi, MarÃa G.. University of Massachussets; Estados UnidosFil: Tourzani, Darya A.. University of Massachussets; Estados UnidosFil: Caraballo, Diego Alfredo. Consejo Nacional de Investigaciones CientÃficas y Técnicas. Oficina de Coordinación Administrativa Ciudad Universitaria. Instituto de EcologÃa, Genética y Evolución de Buenos Aires. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales. Instituto de EcologÃa, Genética y Evolución de Buenos Aires; ArgentinaFil: Jha, Kula N.. No especifÃca;Fil: Teves, Maria E.. University of Virginia; Estados UnidosFil: Cui, Wei. University of Massachussets; Estados UnidosFil: Georg, Gunda I.. University of Minnesota; Estados UnidosFil: Visconti, Pablo E.. University of Massachussets; Estados UnidosFil: Salicioni, Ana M.. University of Massachussets; Estados Unido
Recommended from our members
Mouse sperm energy restriction and recovery (SER) revealed novel metabolic pathways
Mammalian sperm must undergo capacitation to become fertilization-competent. While working on mice, we recently developed a new methodology for treating sperm in vitro, which results in higher rates of fertilization and embryo development after in vitro fertilization. Sperm incubated in media devoid of nutrients lose motility, although they remain viable. Upon re-adding energy substrates, sperm resume motility and become capacitated with improved functionality. Here, we explore how sperm energy restriction and recovery (SER) treatment affects sperm metabolism and capacitation-associated signaling. Using extracellular flux analysis and metabolite profiling and tracing via nuclear magnetic resonance (NMR) and mass spectrometry (MS), we found that the levels of many metabolites were altered during the starvation phase of SER. Of particular interest, two metabolites, AMP and L-carnitine, were significantly increased in energy-restricted sperm. Upon re-addition of glucose and initiation of capacitation, most metabolite levels recovered and closely mimic the levels observed in capacitating sperm that have not undergone starvation. In both control and SER-treated sperm, incubation under capacitating conditions upregulated glycolysis and oxidative phosphorylation. However, ATP levels were diminished, presumably reflecting the increased energy consumption during capacitation. Flux data following the fate of 13C glucose indicate that, similar to other cells with high glucose consumption rates, pyruvate is converted into 13C-lactate and, with lower efficiency, into 13C-acetate, which are then released into the incubation media. Furthermore, our metabolic flux data show that exogenously supplied glucose is converted into citrate, providing evidence that in sperm cells, as in somatic cells, glycolytic products can be converted into Krebs cycle metabolites
Creating a Drosophila SOD1 Mutant Through Homologous Recombination
This works describes the creation and partial phenotypic analysis of a point mutation within the endogenous Drosophila sod gene. The sodS111C allele was generated through a process of mutagenesis and homologous recombination in vivo. SodS111C stocks were created to analyze the mutation’s influence on protein aggregation, if any. We were able to test the effects of this mutant by assessing the function of the protein using genetic assays. To examine the effect of sodS111C on the second chromosome in the presence of sodG85R on the third chromosome appropriate genetic crosses were performed and it was determined that there was no significant difference among the eclosion rates of progenies. All four genotypes of progenies eclosed in Mendelian ratios. This could be explained by the fact that though one class of progeny genotype contained a double mutant sod, there was still the presence of the endogenous sodwt that could have masked for the double mutant
Inhibition of Streptococcus Pneumoniae Autolysins Highlight Distinct Differences Between Chemical and Genetic Inactivation
Despite renewed interest, development of chemical biology methods to study peptidoglycan metabolism has lagged in comparison to the glycobiology field in general. To address this, a panel of diamides were screened against the Gram-positive pathogen Streptococcus pneumoniae to identify inhibitors of bacterial growth. The screen identified the diamide fgkc as a narrow spectrum bacteriostatic inhibitor of S. pneumoniae growth with an MIC of 7.8 μM. The diamide inhibited detergent-induced autolysis in a concentration dependent manner indicating peptidoglycan degradation as the mode-of-action. Genetic screening of autolysin mutants suggested LytB, an endo-N-acetylglucosaminidase, involved in cell division as the potential target. Surprisingly, biochemical, and phenotypic analysis contradicted the genetic screen results. Phenotypic studies with the Δlytb strain illustrate the difference between genetic and chemical inactivation of autolysins. These findings suggest that meta-phenotypes including autolytic activity, cell morphology, and genetic screening can be the result of the complex interaction of one or more possible pathways that are connected to cell wall metabolism
Diamide Inhibitors of the Bacillus subtilis <i>N</i>‑Acetylglucosaminidase LytG That Exhibit Antibacterial Activity
<i>N</i>-Acetylglucosaminidases (GlcNAcases) play an important
role in the remodeling and recycling of bacterial peptidoglycan by
degrading the polysaccharide backbone. Genetic deletions of autolysins
can impair cell division and growth, suggesting an opportunity for
using small molecule autolysin inhibitors both as tools for studying
the chemical biology of autolysins and also as antibacterial agents.
We report here the synthesis and evaluation of a panel of diamides
that inhibit the growth of Bacillus subtilis. Two compounds, <b>fgkc</b> (<b>21</b>) and <b>fgka</b> (<b>5</b>), were found to be potent inhibitors (MIC 3.8 ±
1.0 and 21.3 ± 0.1 μM, respectively). These compounds inhibit
the B. subtilis family 73 glycosyl
hydrolase LytG, an <i>exo</i> GlcNAcase. Phenotypic analysis
of <b>fgkc</b> (<b>21</b>)-treated cells demonstrates
a propensity for cells to form linked chains, suggesting impaired
cell growth and division